Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
August-2018 Volume 16 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
August-2018 Volume 16 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Intrarenal urothelial cancers confused as infiltrative renal masses: Report of 22 cases and literature review

  • Authors:
    • Xiaobo Ding
    • Xiaobo Ma
    • Yatao Jia
    • Hongfei Li
    • Yanbo Wang
  • View Affiliations / Copyright

    Affiliations: Department of Radiology, First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China, Department of Pathology, First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China, Department of Urology, First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China
  • Pages: 1912-1916
    |
    Published online on: June 1, 2018
       https://doi.org/10.3892/ol.2018.8867
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Distinguishing infiltrative renal masses (IRMs) from intrarenal urothelial cancers (IUCs) is critically important, but may be challenging for any radiologist or urologist. The present study aimed to summarize the clinical, imaging and pathological characteristics of IRM, which were postoperatively confirmed as IUC. The analysis was performed using the records of 22 patients who were preoperatively diagnosed with IRM but the results of percutaneous biopsies or postoperative pathological analyses led to diagnoses of urothelial cancers (UCs) from January 2011 to December 2017. The demographic data, computed tomography (CT) imaging features and pathological characteristics were evaluated. The present study also reviewed the literature concerning the IRM and IUC. The mean age of patients was 62 years and 86.4% of them were >55 years. The sex and tumor side distributions were equal. Hematuria and/or flank pain were observed in 86.4% of patients. All patients exhibited endophytic solid renal masses with unclear tumor boundaries on CT images. The kidneys of 81.8% of patients maintained their normal shape while mild alternations were observed in 18.2% of cases. A total of 81.8% of patients maintained the reniform shape and 18.2% exhibited mild contour change. Of all patients, all tumors exhibited less or equal attenuation on unenhanced CT images and they were mildlyimproved on enhanced CT. A total of 6 cases were confirmed by biopsy, when patients underwent laparoscopic nephroureterectomy instead of radical nephrectomy. The remaining 16 patients underwent laparoscopic nephrectomy but the postoperative pathological diagnoses revealed the presence of UCs. All postoperatively confirmed cancers were stages T3 and T4 (62.5 and 37.5%, respectively). UCs should be suspected in middle aged or elderly middle‑elderly patients presenting renal masses with endophytic solid unclear tumor boundary on unenhanced and slightly enhanced CT images, accompanied with hematuria and/or flank pain. Preoperative biopsy is preferred for complicated cases.

Introduction

The most common type of malignant kidney cancer is renal cell carcinoma (RCC), which accounts for 85–90% of cases (1). Primary urothelial cancer (UC) of the upper tract is only diagnosed in about 7–10% of all patients with renal tumors (2,3). Macroscopic hematuria, flank pain and palpable flank mass are three main clinical presentation of RCC but such typical tumors are rare at present due to increasing use of imaging (4). Microscopic or macroscopic hematuria is the most common symptom of UC and symptomatic hydronephrosis occurs if the tumor locates at the ureteropelvic junction (5). Both RCC and UC are more common in men vs. women. RCC originates from proximal convoluted tubule including clear cell renal carcinoma, papillary RCC, chromophobe RCC, collecting duct RCC, renal medullary carcinoma and sarcomatoid RCC (6). While UC arises from the transitional epithelium, including papillary and non-papillary transitional cell carcinomas. Nephron sparing surgery (NSS) or radical nephrectomy are the main procedures for RCC, and radical nephroureterectomy (RNU) with en bloc excision of the periureteric bladder cuff is the standard surgical treatment for UCs (7,8). Computed tomography (CT) is mostly used to preoperative diagnosis of RCC and UC. Typically, the tumors of RCC are soft tissue attenuation and sometimes accompanied with necrosis and calcification, which have stronger or irregular enhancement during the corticomedullary phase. In contrast, for UC, filling defect or distortion of calyces are shown on CT scan and the tumors have mild enhancement during contrast CT (9,10). However, unusual infiltrative renal masses (IRMs) are similar to intrarenal UCs (IUCs) on imaging, which frequently results in misdiagnosis and mistreatment. The present study retrospectively evaluated the patients who were preoperatively diagnosed with IRM, but the subsequent pathological results confirmed UCs in First Hospital of Jilin University. A comprehensive review of the literature was also performed.

Case report

The study protocol was approved by the Institutional Review Board of the First Hospital of Jilin University (Jilin, China). A total of 22 IRM patients with pathologically confirmed IUCs at our institution from January 2011 to December 2017 were included in the present study. Representative cases are shown in Figs. 1 and 2. Detailed clinical and pathological data was available for all patients and the CT images were all performed in First Hospital of Jilin University (Jilin, China).

Figure 1.

A 74-year-old female with a left renal mass. (A) A poorly defined isodense mass was shown on the axial unenhanced CT scan. Mild enhancement occurred on the (B) cortical and (C) nephrographic phases, showing an infiltrative, solid and unclear boundary. (D) Microscopic analysis demonstrated an infiltrative growth of tumor tissues, highly heterogeneous cells with irregular contours, abundant eosinophilic cytoplasm and vacuolar nuclei (hematoxylin and eosin staining, magnification, ×400). CT, computed tomography.

Figure 2.

A 59-year-old male with a right renal mass. The contrast-enhanced CT imaging illustrated a mild enhancement on the (A) cortical and (B) nephrographic phases, exhibiting an endophytic, solid, preserved contour and an unclear boundary. (C) Microscopic analysis indicated papillary infiltrative growth pattern of tissue. Left was the typical UC and the right was squamous differentiation (hematoxylin and eosin staining, magnification, ×100). (D) Positive expression of P63 in tumor cells (immunohistochemical staining, magnification, ×200). CT, computed tomography; UC, urothelial cancer.

Lists of demographic and pathological data of the study cohort are shown in Table I. There were 14 males and 8 females with a median age of 62 years. A total of 11 patients were between 56–65 years (50%) and 8 patients were >65 years old (36.4%). There was no difference between the frequency of occurrence of tumors on the left or right side (11 vs. 10 cases, respectively). Hematuria and/or flank pain were the main symptoms which accounted for 86.4% of patients. One patient was diagnosed during a routine physical examination and another two were initially admitted due to emaciation. Two patients exhibited symptoms of lung metastasis. A total of six patients (27.3%) who underwent laparoscopic nephroureterectomy were diagnosed by percutaneous biopsy. The remaining 16 patients underwent laparoscopic radical nephrectomy but the postoperative pathology led to diagnosis of UCs, among which, 10 (62.5%) were stage T3 and 6 (37.5%) were stage T4. A total of two patients were confirmed positive lymph node.

Table I.

Demographic and pathological data on 22 patients.

Table I.

Demographic and pathological data on 22 patients.

ParametersNo. of patients (%)
Age, yearsa
  45–553 (13.6)
  56–6511 (50)
  >658 (36.4)
Sex
  Male14 (63.6)
  Female8 (36.4)
Side
  Left11 (50)
  Right10 (45.5)
  Both1 (4.5)
Symptoms
  No1 (4.5)
  Hematuria6 (27.3)
  Flank pain6 (27.3)
  Hematuria and flank pain7 (31.8)
  Emaciation2 (9)
Suspected lung metastasis2 (9)
  Biopsy6 (27.3)
Tumor stage
  pT10 (0)
  pT20 (0)
  pT310 (62.5)
  pT46 (37.5)
Positive lymph node2 (9)

a The median age was 62 years (range, 45–80 years).

All tumor features identified in the CT images were shown in Table II. The mean maximum diameter was 4.8 cm. All tumors were endophytic and solid. All tumor boundaries were unclear. The reniform contours of the operated kidneys were completely preserved or mildly altered (81.8 and 18.2%, respectively). In unenhanced CT images, all tumors exhibited isoattenuation or hypoattenuation which were mildly enhanced on enhanced CT images. A total of 2 patients demonstrated lymph node enlargement.

Table II.

CT imaging features of tumor.

Table II.

CT imaging features of tumor.

ParametersNo. of patients (%)
Mean maximus diameter, cm (range)4.8 3.6–6.5
Location
  Endophytic22 (100)
  Exophytic0 (0)
Reniform shape
  No18 (81.8)
  Mild4 (18.2)
  Moderate0 (0)
  Severe0 (0)
Tumor boundary
  Clear0 (0)
  Unclear22 (100)
Component
  Cystic0 (0)
  Necrosis0 (0)
  Solid22 (100)
Unenhanced CT density
  High attenuation0 (0)
  Isoattenuation/hypoattenuation22 (100)
Degree of enhancement on CT
  Mild22 (100)
  Moderate0 (0)
  Severe0 (0)
Lymph node enlargement2 (9)

[i] The mean maximus diameter was 4.8 cm (range, 36–6.5 cm). CT, computed tomography.

Discussion

The surgical treatment and postoperative management of kidney cancers and renal pelvis cancers are significantly different. Therefore, distinguishing IRMs from IUCs is critically important but sometimes challenging (11). UC of the renal pelvis may display an infiltrative growth pattern, which results in a close radiological mimic of IRM.

Certain studies have attempted to differentiate IRM from IUC but the limitations were obvious. Raza et al (12) reviewed CT studies of 64 centrally located RCC and 34 IUC and found that the presence of a tumor centered within the collecting system was the most valuable characteristic identified on the CT images. Bata et al (13), concluded that using multiple small ROIs was valuable for distinguishing IRM from IUC. However, based on one case and literature review, Li et al (14) reported that imaging results of hypovascular RCC were indistinguishable from IUC. Han et al (15), attempted to evaluate the potential systemic inflammatory markers to differentiate between infiltrative RCC and infiltrative UCs. Their analysis indicated that age and lymphocyte-monocyte ratio were significantly different between patients with IRM. To the best of our knowledge, the present study is the first to comprehensively evaluate clinical, imaging and pathological characteristics of IRMs that were postoperatively confirmed as IUCs.

In the present study, 63.6% of the patients were male and 36.4% were female. There was no obvious tendency about sex. Zhu et al (16) retrospectively assessed 29 patients with invasive renal parenchymal urothelial carcinoma (IRPUC) and found that IRPUC was more likely to occur in the right kidney (82.7%). However, in the present study, the ratio of malignancies in left and right kidneys was 11 vs. 10. Raza et al (12), also supported our results. It was observed that prevalence of the disease was increased among middle-elderly patients, over 56 years old (86.4%), which suggests that older age may be associated with the development of IRC.

The mean maximum diameter of tumors was between 3.6 and 6.5 cm. A previous study demonstrated that if such tumors were renal cancers, hematuria and flank pain were infrequent (17). However, in the present study, 27.3% of patients exhibited either a symptom of hematuria or flank pain and 31.8% exhibited both hematuria and flank pain, which indicated that hematuria and/or flank pain were the principal predictive symptoms.

The CT images revealed that all 22 tumors were endophytic and solid. All patients were free from cystic or necrotic alterations. The results were similar to those previously reported by Raza et al (12). RCC may be associated with a moderate or severe renal shape distortion, however, in the present study, a total of 18 patients (81.2%) retained the renal contour and 4 patients (18.2%) underwent mild alteration of shape. However, IRM does not necessarily alter the reniform contour in all patients and certain patients with IUC can sometimes exhibit a distorted renal shape (18,19). An unclear tumor boundary was identified in each case included in the present study, which was an important and valuable CT characteristic. Isoattenuation or hypoattenuation occurred in all patients and were visible in unenhanced CT images and all tumors exhibited poor homogeneous enhancing masses in contrast-enhanced CT images.

Although, several special CT features can help distinguish IRM from IRC, in the majority of cases, other similar neoplasms are present, including renal lymphoma, collecting duct carcinoma, metastasis, xanthogranulomatous pyelonephritis and medullary carcinoma (20,21). Biopsy is a necessary procedure in case of misdiagnosis and mistreatment. Guarnizo et al (22), assessed the diagnostic accuracy of ureteroscopic biopsy and found that ureteroscopic multi-biopsy can lead to an accurate diagnosis of urothelial carcinoma in 89% of cases and can predict the exact histopathological grade in 78% of cases. Furukawa et al (23), assessed a total of 40 patients and found that ureteroscopic biopsy could lead to determination of the pathological grade of nephroureterectomy specimens with an accuracy rate of 87.5%. Recently, Huang et al (24) reviewed 26 cases of upper tract lesions and found that percutaneous biopsy was also a safe and effective method.

In conclusion, it is challenging to thoroughly make a distinction between IRM and IUC preoperatively; however, the elder accompanied with hematuria and/or flank pain are more likely to indicate IRM, who with special CT features: endophytic, solid and unclear tumor boundary on unenhanced CT and slightly enhancement on contrast-enhanced CT. Pre-operative endoscopic or percutaneous biopsy, is a valuable tool for complex cases.

Acknowledgements

Not applicable.

Funding

Dr. Wang was funded by the China Scholarship Council (grant no. 201706175045).

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors' contributions

XD, XM, YJ and HL and YW were all involved in this conception of this study and helped to draft the manuscript. All authors have read and approved the final manuscript.

Ethics approval and consent to participate

Institutional Review Board of the First Hospital of Jilin University (Jilin, China). Verbal informed consent was obtained from the patients.

Consent for publication

Verbal informed consent was obtained from the patients.

Competing interests

The authors declare that they have no competing interests.

References

1 

Sheir KZ, El-Azab M, Mosbah A, El-Baz M and Shaaban AA: Differentiation of renal cell carcinoma subtypes by multislice computerized tomography. J Urol. 174:451–455. 2005. View Article : Google Scholar : PubMed/NCBI

2 

Mandalapu RS and Matin SF: Contemporary evaluation and management of upper tract urothelial cancer. Urology. 94:17–23. 2016. View Article : Google Scholar : PubMed/NCBI

3 

Arancibia MF, Bolenz C, Michel MS, Keeley FX Jr and Alken P: The modern management of upper tract urothelial cancer: Surgical treatment. BJU Int. 99:978–981. 2007. View Article : Google Scholar : PubMed/NCBI

4 

Rossi SH, Klatte T, Usher-Smith J and Stewart GD: Epidemiology and screening for renal cancer. World J Urol. 2 Apr 2018 (Epub ahead of print).

5 

Jaworski D, Szylberg Ł, Gzil A, Stawinski P, Kasperska A and Marszałek A: Diagnostic difficulties in cases of papillary urothelial neoplasm of low malignant potential, urothelial proliferation of uncertain malignant potential, urothelial dysplasia and urothelial papilloma: A review of current literature. Ann Diagn Pathol. 17 Dec. 2017, (Epub ahead of print). View Article : Google Scholar : PubMed/NCBI

6 

Czarniecki M, Gautam R, Choyke PL and Turkbey B: Imaging findings of hereditary renal tumors, a review of what the radiologist should know. Eur J Radiol. 101:8–16. 2018. View Article : Google Scholar : PubMed/NCBI

7 

Pierorazio PM, Johnson MH, Patel HD, Sozio SM, Sharma R, Iyoha E, Bass EB and Allaf ME: Management of renal masses and localized renal cancer: Systematic review and meta-analysis. J Urol. 196:989–999. 2016. View Article : Google Scholar : PubMed/NCBI

8 

Soria F, Shariat SF, Lerner SP, Fritsche HM, Rink M, Kassouf W, Spiess PE, Lotan Y, Ye D, Fernández MI, et al: Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC). World J Urol. 35:379–387. 2017. View Article : Google Scholar : PubMed/NCBI

9 

Nabi S, Kessler ER, Bernard B, Flaig TW and Lam ET: Renal cell carcinoma: A review of biology and pathophysiology. F1000Res. 7:3072018. View Article : Google Scholar : PubMed/NCBI

10 

Froemming A, Potretzke T, Takahashi N and Kim B: Upper tract urothelial cancer. Eur J Radiol. 98:50–60. 2018. View Article : Google Scholar : PubMed/NCBI

11 

Hartman DS, Davidson AJ, Davis CJ Jr and Goldman SM: Infiltrative renal lesions: CT-sonographic-pathologic correlation. AJR Am J Roentgenol. 150:1061–1064. 1988. View Article : Google Scholar : PubMed/NCBI

12 

Raza SA, Sohaib SA, Sahdev A, Bharwani N, Heenan S, Verma H and Patel U: Centrally infiltrating renal masses on CT: differentiating intrarenal transitional cell carcinoma from centrally located renal cell carcinoma. AJR Am J Roentgenol. 198:846–853. 2012. View Article : Google Scholar : PubMed/NCBI

13 

Bata P, Tarnoki DL, Tarnoki AD, Novak PK, Gyebnar J, Kekesi D, Szendroi A, Fejer B, Szasz AM, Nyirady P, et al: Transitional cell and clear cell renal carcinoma: Differentiation of distinct histological types with multiphase CT. Acta Radiol. 55:1112–1119. 2014. View Article : Google Scholar : PubMed/NCBI

14 

Li Y, Ding YU, Chen D, Yu Z, Gui Y, Yang S and Lai Y: Renal cell carcinoma growing into the renal pelvis and mimicking transitional cell carcinoma: A case report and literature review. Oncol Lett. 9:1869–1872. 2015. View Article : Google Scholar : PubMed/NCBI

15 

Han JH, Yoon YE, Kim SY, Cho YI, Rha KH, Choi YD and Han WK: Preoperative lymphocyte-monocyte ratio ameliorates the accuracy of differential diagnosis in non-metastatic infiltrative renal masses. Yonsei Med J. 58:388–394. 2017. View Article : Google Scholar : PubMed/NCBI

16 

Zhu Q, Zhu W, Wu J and Chen W: Multidetector CT imaging features of invasive renal parenchyma urothelial carcinoma. Br J Radiol. 89:201510682016. View Article : Google Scholar : PubMed/NCBI

17 

Ginzburg S, Tomaszewski JJ and Kutikov A: Focal ablation therapy for renal cancer in the era of active surveillance and minimally invasive partial nephrectomy. Nat Rev Urol. 14:669–682. 2017. View Article : Google Scholar : PubMed/NCBI

18 

Prando A, Prando P and Prando D: Urothelial cancer of the renal pelvicaliceal system: Unusual imaging manifestations. Radiographics. 30:1553–1566. 2010. View Article : Google Scholar : PubMed/NCBI

19 

Yoon SK, Nam KJ, Rha SH, Kim JK, Cho KS, Kim B, Kim KH and Kim KA: Collecting duct carcinoma of the kidney: CT and pathologic correlation. Eur J Radiol. 57:453–460. 2006. View Article : Google Scholar : PubMed/NCBI

20 

Blitman NM, Berkenblit RG, Rozenblit AM and Levin TL: Renal medullary carcinoma: CT and MRI features. AJR Am J Roentgenol. 185:268–272. 2005. View Article : Google Scholar : PubMed/NCBI

21 

Yan Y, Liu L, Zhou J, Li L, Li Y, Chen M, Wang L, He W, Guan X, Zu X and Qi L: Clinicopathologic characteristics and prognostic factors of sarcomatoid renal cell carcinoma. J Cancer Res Clin Oncol. 141:345–352. 2015. View Article : Google Scholar : PubMed/NCBI

22 

Guarnizo E, Pavlovich CP, Seiba M, Carlson DL, Vaughan ED Jr and Sosa RE: Ureteroscopic biopsy of upper tract urothelial carcinoma: Improved diagnostic accuracy and histopathological considerations using a multi-biopsy approach. J Urol. 163:52–55. 2000. View Article : Google Scholar : PubMed/NCBI

23 

Furukawa J, Miyake H, Sakai I and Fujisawa M: Significance of ureteroscopic biopsy grade in patients with upper tract urothelial carcinoma. Curr Urol. 6:156–159. 2013. View Article : Google Scholar : PubMed/NCBI

24 

Huang SY, Ahrar K, Gupta S, Wallace MJ, Ensor JE, Krishnamurthy S and Matin SF: Safety and diagnostic accuracy of percutaneous biopsy in upper tract urothelial carcinoma. BJU Int. 115:625–632. 2015. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Ding X, Ma X, Jia Y, Li H and Wang Y: Intrarenal urothelial cancers confused as infiltrative renal masses: Report of 22 cases and literature review. Oncol Lett 16: 1912-1916, 2018.
APA
Ding, X., Ma, X., Jia, Y., Li, H., & Wang, Y. (2018). Intrarenal urothelial cancers confused as infiltrative renal masses: Report of 22 cases and literature review. Oncology Letters, 16, 1912-1916. https://doi.org/10.3892/ol.2018.8867
MLA
Ding, X., Ma, X., Jia, Y., Li, H., Wang, Y."Intrarenal urothelial cancers confused as infiltrative renal masses: Report of 22 cases and literature review". Oncology Letters 16.2 (2018): 1912-1916.
Chicago
Ding, X., Ma, X., Jia, Y., Li, H., Wang, Y."Intrarenal urothelial cancers confused as infiltrative renal masses: Report of 22 cases and literature review". Oncology Letters 16, no. 2 (2018): 1912-1916. https://doi.org/10.3892/ol.2018.8867
Copy and paste a formatted citation
x
Spandidos Publications style
Ding X, Ma X, Jia Y, Li H and Wang Y: Intrarenal urothelial cancers confused as infiltrative renal masses: Report of 22 cases and literature review. Oncol Lett 16: 1912-1916, 2018.
APA
Ding, X., Ma, X., Jia, Y., Li, H., & Wang, Y. (2018). Intrarenal urothelial cancers confused as infiltrative renal masses: Report of 22 cases and literature review. Oncology Letters, 16, 1912-1916. https://doi.org/10.3892/ol.2018.8867
MLA
Ding, X., Ma, X., Jia, Y., Li, H., Wang, Y."Intrarenal urothelial cancers confused as infiltrative renal masses: Report of 22 cases and literature review". Oncology Letters 16.2 (2018): 1912-1916.
Chicago
Ding, X., Ma, X., Jia, Y., Li, H., Wang, Y."Intrarenal urothelial cancers confused as infiltrative renal masses: Report of 22 cases and literature review". Oncology Letters 16, no. 2 (2018): 1912-1916. https://doi.org/10.3892/ol.2018.8867
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team